目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Technology
Market segments
Comparison by Technology
CTC and ctDNA - Market size and forecast 2020-2025
Exosome and RNA - Market size and forecast 2020-2025
Market opportunity by Technology

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
ANGLE Plc
Bio Techne Corp.
Biocept Inc.
CIRCULOGENE
F. Hoffmann-La Roche Ltd.
Guardant Health Inc.
LungLife AI Inc.
Myriad Genetics Inc.
QIAGEN NV
SAGA Diagnostics AB

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Technology - Market share 2020-2025 (%)
22: Comparison by Technology
23: CTC and ctDNA - Market size and forecast 2020-2025 ($ million)
24: CTC and ctDNA - Year-over-year growth 2020-2025 (%)
25: Exosome and RNA - Market size and forecast 2020-2025 ($ million)
26: Exosome and RNA - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Technology
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: ANGLE Plc - Overview
48: ANGLE Plc - Product and service
49: ANGLE Plc - Key offerings
50: ANGLE Plc - Key customers
51: ANGLE Plc - Segment focus
52: Bio Techne Corp. - Overview
53: Bio Techne Corp. - Business segments
54: Bio Techne Corp. - Key offerings
55: Bio Techne Corp. - Key customers
56: Bio Techne Corp. - Segment focus
57: Biocept Inc. - Overview
58: Biocept Inc. - Product and service
59: Biocept Inc. - Key offerings
60: Biocept Inc. - Key customers
61: Biocept Inc. - Segment focus
62: CIRCULOGENE - Overview
63: CIRCULOGENE - Product and service
64: CIRCULOGENE - Key offerings
65: CIRCULOGENE - Key customers
66: CIRCULOGENE - Segment focus
67: F. Hoffmann-La Roche Ltd. - Overview
68: F. Hoffmann-La Roche Ltd. - Business segments
69: F. Hoffmann-La Roche Ltd. - Key offerings
70: F. Hoffmann-La Roche Ltd. - Key customers
71: F. Hoffmann-La Roche Ltd. - Segment focus
72: Guardant Health Inc. - Overview
73: Guardant Health Inc. - Business segments
74: Guardant Health Inc. - Key offerings
75: Guardant Health Inc. - Key customers
76: Guardant Health Inc. - Segment focus
77: LungLife AI Inc. - Overview
78: LungLife AI Inc. - Product and service
79: LungLife AI Inc. - Key offerings
80: LungLife AI Inc. - Key customers
81: LungLife AI Inc. - Segment focus
82: Myriad Genetics Inc. - Overview
83: Myriad Genetics Inc. - Business segments
84: Myriad Genetics Inc. - Key offerings
85: Myriad Genetics Inc. - Key customers
86: Myriad Genetics Inc. - Segment focus
87: QIAGEN NV - Overview
88: QIAGEN NV - Business segments
89: QIAGEN NV - Key offerings
90: QIAGEN NV - Key customers
91: QIAGEN NV - Segment focus
92: SAGA Diagnostics AB - Overview
93: SAGA Diagnostics AB - Product and service
94: SAGA Diagnostics AB - Key offerings
95: SAGA Diagnostics AB - Key customers
96: SAGA Diagnostics AB - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations